Commonalities and distinctions between the type 2 diabetes mellitus and Alzheimer's disease: a systematic review and multimodal neuroimaging meta-analysis

• Published in: Frontiers in neuroscience 2023-12, Vol.17, p.1301778-1301778
• Main Authors: Xie, Hao, Yu, Ying, Yang, Yang, Sun, Qian, Li, Ze-Yang, Ni, Min-Hua, Li, Si-Ning, Dai, Pan, Cui, Yan-Yan, Cao, Xin-Yu, Jiang, Nan, Du, Li-Juan, Gao, Wen, Bi, Jia-Jun, Yan, Lin-Feng, Cui, Guang-Bin
• Format: Article
• Language: English
• Subjects: Alzheimer's disease; Blood flow; Brain damage; Brain mapping; Brain research; Cerebellum; Cerebral blood flow; Cognitive ability; Comorbidity; coordinated-based meta-analysis; Cortex (parietal); Dementia; Diabetes; Diabetes mellitus (non-insulin dependent); Disease; Functional magnetic resonance imaging; functional neuroimaging; Health care; Image processing; Insulin resistance; Magnetic resonance imaging; Medical imaging; Meta-analysis; Metabolism; Neostriatum; Nervous system; Neurodegenerative diseases; Neuroimaging; Neuroscience; Occipital lobe; Parietal lobe; Signal transduction; Superior temporal gyrus; Supplementary motor area; Temporal gyrus; Tomography; type 2 diabetes mellitus
• ISSN: 1662-4548; 1662-453X; 1662-453X
• DOI: 10.3389/fnins.2023.1301778

Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are aging related diseases with high incidence. Because of the correlation of incidence rate and some possible mechanisms of comorbidity, the two diseases have been studied in combination by many researchers, and even some scholars call AD type 3 diabetes. But the relationship between the two is still controversial. This study used seed-based d mapping software to conduct a meta-analysis of the whole brain resting state functional magnetic resonance imaging (rs-fMRI) study, exploring the differences in amplitude low-frequency fluctuation (ALFF) and cerebral blood flow (CBF) between patients (AD or T2DM) and healthy controls (HCs), and searching for neuroimaging evidence that can explain the relationship between the two diseases. The final study included 22 datasets of ALFF and 22 datasets of CBF. The results of T2DM group showed that ALFF increased in both cerebellum and left inferior temporal gyrus regions, but decreased in left middle occipital gyrus, right inferior occipital gyrus, and left anterior central gyrus regions. In the T2DM group, CBF increased in the right supplementary motor area, while decreased in the middle occipital gyrus and inferior parietal gyrus. The results of the AD group showed that the ALFF increased in the right cerebellum, right hippocampus, and right striatum, while decreased in the precuneus gyrus and right superior temporal gyrus. In the AD group, CBF in the anterior precuneus gyrus and inferior parietal gyrus decreased. Multimodal analysis within a disease showed that ALFF and CBF both decreased in the occipital lobe of the T2DM group and in the precuneus and parietal lobe of the AD group. In addition, there was a common decrease of CBF in the right middle occipital gyrus in both groups. Based on neuroimaging evidence, we believe that T2DM and AD are two diseases with their respective characteristics of central nervous activity and cerebral perfusion. The changes in CBF between the two diseases partially overlap, which is consistent with their respective clinical characteristics and also indicates a close relationship between them. PROSPERO [CRD42022370014].